Speaker

Carole Longson has over 30 years of executive and board experience in life sciences and is an internationally respected leader in Health Technology Assessment and Market Access. After a career in drug discovery at GSK, she spent 18 years at NICE pioneering its Technology Appraisal and Health Tech Evaluation programs, later serving as Chief Scientific Officer at the Association of the British Pharmaceutical Industry. A former HTAi President and EUnetHTA Executive Committee member, she has advised the European Commission and WHO. She is currently Vice Chair of Medicines Discovery Catapult UK and senior counsel in HTA and market access.